(19)
(11) EP 3 640 248 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 2 (W2 B1)

(48) Corrigendum issued on:
29.11.2023 Bulletin 2023/48

(45) Mention of the grant of the patent:
23.08.2023 Bulletin 2023/34

(21) Application number: 18817102.9

(22) Date of filing: 13.06.2018
(51) International Patent Classification (IPC): 
C07D 403/04(2006.01)
A61K 31/381(2006.01)
A61K 31/497(2006.01)
A61K 31/54(2006.01)
A61P 35/02(2006.01)
C07D 417/04(2006.01)
A61K 31/416(2006.01)
A61K 31/506(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61P 35/02; C07D 401/14; C07D 403/04; C07D 403/14; C07D 405/14; C07D 413/14; C07D 417/04; C07D 487/08; C07D 491/107; C07D 403/10; C07D 417/10; C07D 417/14
(86) International application number:
PCT/CN2018/091114
(87) International publication number:
WO 2018/228446 (20.12.2018 Gazette 2018/51)

(54)

AMINOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF

AMINOPYRIMIDINDERIVATE, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG DAVON

DÉRIVÉS D'AMINOPYRIMIDINE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 13.06.2017 CN 201710445095

(43) Date of publication of application:
22.04.2020 Bulletin 2020/17

(73) Proprietor: Beijing Avistone Biotechnology Co., Ltd.
Beijing 100102 (CN)

(72) Inventors:
  • ZHANG, Peilong
    Beijing 100102 (CN)
  • SHI, Hepeng
    Beijing 100102 (CN)
  • LAN, Wenli
    Beijing 100102 (CN)
  • SONG, Zhitao
    Beijing 100102 (CN)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)


(56) References cited: : 
WO-A1-2009/158571
WO-A1-2017/120429
WO-A1-2019/010295
CN-A- 105 085 489
WO-A1-2015/188747
WO-A1-2018/019204
CN-A- 104 860 941
CN-A- 105 315 285
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).